Orient Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ORIENT PHARMA, and what generic and branded alternatives to ORIENT PHARMA drugs are available?
ORIENT PHARMA has five approved drugs.
Summary for Orient Pharma
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Orient Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orient Pharma Co Ltd | CARISOPRODOL | carisoprodol | TABLET;ORAL | 205085-001 | Oct 28, 2014 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Orient Pharma Co Ltd | GLYBURIDE | glyburide | TABLET;ORAL | 206483-001 | Feb 22, 2019 | AB1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Orient Pharma | EZETIMIBE | ezetimibe | TABLET;ORAL | 215693-001 | Sep 13, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
